OPEN ClinicoEconomics and outcomes research : CEOR | 6 Oct 2016
F Ramponi, C Ronco, G Mason, E Rettore, D Marcelli, F Martino, M Neri, A Martin-Malo, B Canaud and F Locatelli
Clinical studies suggest that hemodiafiltration (HDF) may lead to better clinical outcomes than high-flux hemodialysis (HF-HD), but concerns have been raised about the cost-effectiveness of HDF versus HF-HD. Aim of this study was to investigate whether clinical benefits, in terms of longer survival and better health-related quality of life, are worth the possibly higher costs of HDF compared to HF-HD.
* Data courtesy of Altmetric.com